May 25, 2020
Regeneron Announces Secondary Offering of its Common Stock Held by Sanofi and $5 Billion Stock Repurchase
Mar 16, 2020
Kodiak Sciences Announces Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
Feb 06, 2020
Regeneron Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
Jan 13, 2020
Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular degeneration (AMD) and Diabetic Macular Oedema (DMO)
Nov 22, 2019
Regeneron's Yancopoulos Receives Columbia College's Alexander Hamilton Award
Nov 12, 2019
Kodiak Sciences Announces Third Quarter 2019 Financial Results and Recent Business Highlights
Nov 11, 2019
Wet Age-Related Macular Degeneration Market by Product, by Distribution Channel, by Age Group, by Route of Administration, by End User, by Geography Global Market Size, Share, Development, Growth, and Demand Forecast, 2014-2024
Nov 05, 2019
Regeneron Reports Third Quarter 2019 Financial and Operating Results
Oct 22, 2019
U.S. Food & Drug Administration Approves New Wet Age-Related Macular Degeneration Treatment
Oct 10, 2019
Kodiak Sciences Treats First Patients in DAZZLE Pivotal Study of KSI-301 in Wet Age-Related Macular Degeneration
Oct 08, 2019
Novartis receives FDA approval for BEOVU®, offering wet AMD patients vision gains and greater fluid reductions vs aflibercept
Aug 14, 2019
Kodiak Sciences Announces Second Quarter 2019 Financial Results and Recent Business Highlights
Aug 06, 2019
Global Wet Age-Related Macular Degeneration Markets, 2014-2018 & 2019-2024 - Positive Clinical Trial Results and Increasing Approvals for Pipeline Drugs
Aug 06, 2019
Regeneron Reports Second Quarter 2019 Financial and Operating Results
Aug 06, 2019
Dupixent® (dupilumab) Showed Positive Topline Results in Phase 3 Trial of Children Aged 6 to 11 Years with Severe Atopic Dermatitis
Jun 26, 2019
FDA Approves Dupixent® (dupilumab) for Chronic Rhinosinusitis with Nasal Polyposis
Jun 21, 2019
Regeneron and Sanofi Announce Positive Topline Phase 2 Results for IL-33 Antibody in Asthma
Jun 14, 2019
Regeneron CD20xCD3 Bispecific REGN1979 Shows Positive Results in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma, including in CAR-T Failures
May 16, 2019
Updated Libtayo® (cemiplimab-rwlc) Results Reinforce Durable and Substantial Response Rates in Advanced Cutaneous Squamous Cell Carcinoma
May 13, 2019
FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy